Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and…
“I asked OpenAI Astra Ultra + Anthropic Fable 5.1 Max to make me a 5x-10x return type portfolio in 1 year. Burnt a lot of credits, and the results are in: OpenAI: - $KYTX (autoimmune CAR-T results) - $PRQR (human RNA-editing datasets) - $VSTM (KRAS cancer-drug) - $CNTB (asthma and COPD) - $RANI (oral biologics) - $IVA (MASH) - $SILC (networking + inference hardware) - $AMPX (batteries) - $EOSE …” post →
| Date | Tweet |
|---|---|
| 2026-09-06T14:23:02 | I asked OpenAI Astra Ultra + Anthropic Fable 5.1 Max to make me a 5x-10x return type portfolio in 1 year. Burnt a lot of credits, and the results are in: OpenAI: - $KYTX (autoimmune CAR-T results) - $PRQR (human RNA-editing datasets) - $VSTM (KRAS cancer-drug) - $CNTB (asthma and COPD) - $RANI (… → · 4993 likes · 1,338,791 views |
from2028 — cross-site stock view. Rebuilt at publish time.